California-based Azalea Therapeutics, a biotech promising to redefine precision genomic medicines in vivo, has announced its ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...

Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge, gene-editing therapy fashioned ...